000 | 01306 a2200385 4500 | ||
---|---|---|---|
005 | 20250513224025.0 | ||
264 | 0 | _c20001130 | |
008 | 200011s 0 0 fre d | ||
022 | _a0007-4551 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBréchot, J M | |
245 | 0 | 0 |
_a[Role of carboplatin in the treatment of lung cancer]. _h[electronic resource] |
260 |
_bBulletin du cancer _cAug 2000 |
||
300 |
_a34-9 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article; Review | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 | _aArea Under Curve |
650 | 0 | 4 |
_aCarboplatin _xtherapeutic use |
650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
650 | 0 | 4 |
_aCarcinoma, Small Cell _xdrug therapy |
650 | 0 | 4 | _aChemotherapy, Adjuvant |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
650 | 0 | 4 | _aMiddle Aged |
773 | 0 |
_tBulletin du cancer _gvol. 87 Spec No _gp. 34-9 |
|
999 |
_c11024378 _d11024378 |